Jeong Tae Heum

Director at REXAHN PHARMACEUTICALS, INC. · on record since Apr 23, 2008
Director at MetaVia Inc. · on record since Dec 30, 2019
Chief Finance Officer at Clene Inc. · on record since Jan 4, 2021
CFO and Secretary at REXAHN PHARMACEUTICALS, INC. · on record since May 17, 2005

Insider trading activity of Jeong Tae Heum

Transactions on record: 34; since May 17, 2005

Open-market buys: 2; $11.3K

Open-market sells: 4; $322.5K

Companies traded: 3; last filing Nov 4, 2021

Figures computed from official regulatory filings — .

Companies where Jeong Tae Heum has traded

Clene Inc.3 tx · $851.5K · Nov 4, 2021
MetaVia Inc.1 tx · Jan 15, 2020
REXAHN PHARMACEUTICALS, INC.30 tx · $659.9K · Jan 24, 2017

Track record of Jeong Tae Heum

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Jeong Tae Heum

Co-insiders of Jeong Tae Heum

Price Ben GilMetaVia Inc. +1
Sooch MinaMetaVia Inc. +1
Swirsky Douglas JMetaVia Inc. +1
Ahn Chang HoREXAHN PHARMACEUTICALS, INC.
Ahn InokREXAHN PHARMACEUTICALS, INC.
Ainsworth SeanREXAHN PHARMACEUTICALS, INC.
AK Holding Company, LCClene Inc.
Bakshi AkashMetaVia Inc.
Beever CharlesREXAHN PHARMACEUTICALS, INC.
Benaim ElyREXAHN PHARMACEUTICALS, INC.
Bennett JeanREXAHN PHARMACEUTICALS, INC.
Benton SusanREXAHN PHARMACEUTICALS, INC.
Bisgaier Charles PhDMetaVia Inc.
Brandt Peter C.REXAHN PHARMACEUTICALS, INC.
BROWN MORGAN RClene Inc.
CARTHY MARKREXAHN PHARMACEUTICALS, INC.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Clene Inc.	Nov 4, 2021	AwardD (derivative)	62,500	0.00 USD	—	SEC
Clene Inc.	Apr 30, 2021	AwardD (derivative)	20,000	0.00 USD	—	SEC
Clene Inc.	Feb 3, 2021	AwardD (derivative)	130,000	6.55 USD	$851.5K	SEC
MetaVia Inc.	Jan 15, 2020	AwardD (derivative)	60,000	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 24, 2017	AwardD (derivative)	300,000	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 24, 2017	AwardD (derivative)	63,000	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Feb 1, 2016	AwardD (derivative)	100,000	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Feb 1, 2016	AwardD (derivative)	98,853	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 27, 2015	AwardD (derivative)	333,332	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	Sell	-188,690	0.92 USD	$173.6K	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	Exercise	188,690	0.80 USD	$151K	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	ExerciseD (derivative)	-188,690	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	Sell	-78,782	0.90 USD	$70.9K	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	Sell	-49,800	0.91 USD	$45.3K	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	Exercise	49,800	0.80 USD	$39.8K	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	ExerciseD (derivative)	-49,800	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	Exercise	78,782	0.80 USD	$63K	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	ExerciseD (derivative)	-78,782	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 14, 2014	AwardD (derivative)	175,000	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Sep 11, 2013	Other	-78,861	0.46 USD	$36.3K	SEC
REXAHN PHARMACEUTICALS, INC.	Sep 11, 2013	ExerciseD (derivative)	-150,000	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Sep 11, 2013	Sell	-71,139	0.46 USD	$32.7K	SEC
REXAHN PHARMACEUTICALS, INC.	Sep 11, 2013	Exercise	150,000	0.24 USD	$36K	SEC
REXAHN PHARMACEUTICALS, INC.	Mar 5, 2013	AwardD (derivative)	250,000	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 30, 2009	AwardD (derivative)	250,000	0.00	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Clene Inc.	Nov 4, 2021	AwardD (derivative)	62,500	0.00 USD	—	SEC
Clene Inc.	Apr 30, 2021	AwardD (derivative)	20,000	0.00 USD	—	SEC
Clene Inc.	Feb 3, 2021	AwardD (derivative)	130,000	6.55 USD	$851.5K	SEC
MetaVia Inc.	Jan 15, 2020	AwardD (derivative)	60,000	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 24, 2017	AwardD (derivative)	300,000	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 24, 2017	AwardD (derivative)	63,000	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Feb 1, 2016	AwardD (derivative)	100,000	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Feb 1, 2016	AwardD (derivative)	98,853	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 27, 2015	AwardD (derivative)	333,332	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	Sell	-188,690	0.92 USD	$173.6K	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	Exercise	188,690	0.80 USD	$151K	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	ExerciseD (derivative)	-188,690	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	Sell	-78,782	0.90 USD	$70.9K	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	Sell	-49,800	0.91 USD	$45.3K	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	Exercise	49,800	0.80 USD	$39.8K	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	ExerciseD (derivative)	-49,800	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	Exercise	78,782	0.80 USD	$63K	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 12, 2015	ExerciseD (derivative)	-78,782	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 14, 2014	AwardD (derivative)	175,000	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Sep 11, 2013	Other	-78,861	0.46 USD	$36.3K	SEC
REXAHN PHARMACEUTICALS, INC.	Sep 11, 2013	ExerciseD (derivative)	-150,000	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Sep 11, 2013	Sell	-71,139	0.46 USD	$32.7K	SEC
REXAHN PHARMACEUTICALS, INC.	Sep 11, 2013	Exercise	150,000	0.24 USD	$36K	SEC
REXAHN PHARMACEUTICALS, INC.	Mar 5, 2013	AwardD (derivative)	250,000	0.00 USD	—	SEC
REXAHN PHARMACEUTICALS, INC.	Jan 30, 2009	AwardD (derivative)	250,000	0.00	—	SEC